Management: Part II--Drugs

Lean, Mike; Finer, Nick
October 2006
BMJ: British Medical Journal (International Edition);10/14/2006, Vol. 331 Issue 7572, p794
Academic Journal
The article offers a look at drug treatment for obesity. Although diet and exercise play the most important role in weight loss, effective drugs against obesity should reduce energy assimilation from food or stimulate energy expenditure. The article discusses weight loss, weight maintenance, symptoms and risk factors, duration of treatment, and side effects.


Related Articles

  • Xenical. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p809 

    An encyclopedia entry for "Xenical" is presented. It refers to a brand name of a drug pharmacologically called orlistat. The drug Xenical is commonly used for the treatment of patients who are exhibiting symptoms of mild to moderate obesity and more on those who are already on the stage of...

  • OBESITY TREATMENTS. Haslam, David // Pulse;10/31/2007, Vol. 67 Issue 39, p40 

    The author discusses several information on treatments for obesity. The author talks about the therapeutics that can be applied in alleviating corpulence. He includes the historical background for obesity treatment including mercury, arsenic, and strychnine. At the same time, he also cites the...

  • The Current Status and Future Perspectives of Studies of Cannabinoid Receptor 1 Antagonists as Anti-Obesity Agents. Hyeon-Kyu Lee; Eun Bok Choi; Chwang Siek Pak // Current Topics in Medicinal Chemistry;Apr2009, Vol. 9 Issue 6, p482 

    Since the discovery of rimonabant (Acomplia: 1), a large effort has been directed at the discovery of new, potent and selective CB1R antagonists that serve as anti obesity drugs. As a result, a number of compounds reached various stages of clinical trials by late 2008. However, the announcement...

  • ORLISTAT.  // Complete Guide to Prescription & Nonprescription Drugs 2012;2012, p622 

    The article presents information on orlistat, an antiobesity drug and lipase inhibitor, including its dosage, usage, adverse reactions, side effects, precautions when administering, and possible interaction with other drugs.

  • The unrelenting fall of the pharmacological treatment of obesity. Di Dalmazi, Guido; Vicennati, Valentina; Pasquali, Renato; Pagotto, Uberto // Endocrine (1355008X);Dec2013, Vol. 44 Issue 3, p598 

    Nowadays pharmacological therapy to limit obesity has reached a critical stage: not only have Authorities limited the use of antiobesity drugs due to their proven inefficacy and dangerous side effects, but bariatric surgery has delivered better results. At present, when the number of obese...

  • orlistat. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p569 

    An encyclopedia entry for "orlistat" is presented. It refers to an anti-obesity drug used with a slimming diet for the treatment of severe obesity. It is different from appetite suppressants in that orlistat acts on the gastrointestinal tract, preventing the digestion of fats by lipases. The...

  • Weight-Loss Aid Alert. Calechman, Steve // Natural Health;Dec2002, Vol. 32 Issue 9, p24 

    Reports on the warning of U.S. Food and Drug Administration against using two Chinese weight-loss supplements Chasu Jianfei Diet Capsules and Chasu Gempi due to health problems in Japan.

  • Chinese slimming capsules poisoning people.  // Asian Pacific Post;4/16/2009, p10 

    The article reveals the side effects and serious health problems caused by Chinese slimming capsules available on the Internet.

  • Foreign product alert from Health Canada.  // Reactions Weekly;12/11/2010, Issue 1331, p5 

    The article reports on the Foreign Product Alerts issued by Health Canada concerning the use of weight loss products such as Goya-Bitter Melon, Miyura Fit'x Capsules, and two unnamed products.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics